Abstract
To evaluate the diagnostic value of GeneXpert MTB/RIF for diagnosis of tuberculous
meningitis (TBM). Methods: A total of 137 patients with suspected TBM were prospectively recruited. Samples
of cerebrospinal fluid were collected from all patients, and tested by acid fast staining, mycobacterial culture and
GeneXpert MTB/RIF. The performance of GeneXpert MTB/RIF was evaluated by two reference standards,
clinical diagnosis and mycobacterial culture, respectively. Results: Of the 137 enrolled subjects, 124 cases
(90.5% ) had a final diagnosis, with 51 cases being diagnosed definitive TBM and 73 cases being diagnosed
non-TBM. When clinical diagnosis was used as the reference standard, the sensitivities of GeneXpert MTB/RIF?
acid fast staining ? mycobacterial culture were 25.5% (13/51) ? 3.9% (2/51) ? 17.6% (9/51), respectively. The
specificities of the three methods were all 100%. The sensitivity of GeneXpert MTB/RIF was comparable to that
of mycobacterial culture (P=0.336), and was significantly higher than that of acid fast staining (P=0.002). When
mycobacterial culture was used as the reference standard, the sensitivity of GeneXpert MTB/RIF was 88.9%,and
specificity was 100% . Rifampin resistance was not found in the 13 positive results of GeneXpert MTB / RIF
assay, which was consistent with traditional drug susceptibility test. Conclusion: GeneXpert MTB / RIF is a
simple and rapid diagnostic method with high specificity for Mtb detection
Key words
tuberculous meningitis
Cite this article
Download Citations
Evaluation of GeneXpert MTB/RIF for Diagnosis of Tuberculous Meningitis[J]. Neural Injury and Functional Reconstruction. 2018, 13(7): 344-347
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}